TITLE:
Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD

CONDITION:
Substance Use Disorders

INTERVENTION:
Atomoxetine

SUMMARY:

      The purpose of this study is to compare the effectiveness and safety of atomoxetine in the
      treatment of adolescents with coexisting alcohol or substance use disorders and Attention
      Deficit Hyperactivity Disorder (ADHD).
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 13 Years to 18 Years
Criteria:

        Inclusion Criteria:

          -  Adolescents, ages 13-18

          -  Meets criteria for alcohol and/or substance use disorder and attention deficit
             hyperactivity disorder.

        Exclusion Criteria:

          -  Adolescents who are pregnant.

          -  Have a history of seizure disorder, other neurological or medical disorder for which
             medication treatment may present a considerable risk.

          -  History of pervasive development disorder, schizophrenia or other psychotic
             disorders, organic mental disorders or eating disorders.

          -  Currently on other psychotropic medications from which discontinuation would present
             a significant risk.

          -  A current episode of major depressive disorder or a diagnosis of bipolar disorder.

          -  Diagnosis of dependence for any substance other than marijuana.

          -  Adolescents with a full-scale IQ below 80.
      
